Authors: Probert, L Akassoglou, K

Citation: L. Probert et K. Akassoglou, Glial expression of tumor necrosis factor in transgenic animals: How do these models reflect the "normal situation"?, GLIA, 36(2), 2001, pp. 212-219

Authors: Brodsky, S Chen, J Lee, A Akassoglou, K Norman, J Goligorsky, MS

Citation: S. Brodsky et al., Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis, AM J P-HEAR, 281(4), 2001, pp. H1784-H1792

Authors: Akassoglou, K Kombrinck, KW Degen, JL Strickland, S

Citation: K. Akassoglou et al., Tissue plasminogen activator-mediated fibrinolysis protects against axonaldegeneration and demyelination after sciatic nerve injury, J CELL BIOL, 149(5), 2000, pp. 1157-1166

Authors: Probert, L Eugster, HP Akassoglou, K Bauer, J Frei, K Lassmann, H Fontana, A

Citation: L. Probert et al., TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease, BRAIN, 123, 2000, pp. 2005-2019

Authors: Kassiotis, G Bauer, J Akassoglou, K Lassmann, H Kollias, G Probert, L

Citation: G. Kassiotis et al., A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice, EUR J IMMUN, 29(3), 1999, pp. 912-917

Authors: Aloe, L Properzi, F Probert, L Akassoglou, K Kassiotis, G Micera, A Fiore, M

Citation: L. Aloe et al., Learning abilities, NGF and BDNF brain levels in two lines of TNF-alpha transgenic mice, one characterized by neurological disorders, the other phenotypically normal, BRAIN RES, 840(1-2), 1999, pp. 125-137